Kitov Pharma Ltd ADR (USD)
KTOV
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.70 | 0.72
52-Wk Range0.56 | 2.92
Last Close0.72
Mkt Cap (m)13.85
Dividend yield-
ISINUS49803V1070
Volume35,459
Exchange VenueNAS

Company Profile

Kitov Pharma Ltd is engaged in the development of a combination drug that aims to treat osteoarthritis (OA) pain and hypertension called KIT-302 and NT219.

Key Information
Price/Earning-
Price/Book1.28
Price/Sales12.69
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -856.90
Net Margin %-520.00
Return on Equity-58.31
Debt/Equity-

Legal Documents

Prospectus
en 02/10/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)--1
Operating Income (m)-1-5-4-7-12-9
Net Income (m)-3-5-4-12-12-5
Basic EPS--1.38-4.40-2.20-1.40-0.39
Avg. Diluted Shares Outstanding (m)-416914
Balance Sheet
USD201320142015201620172018
Current Assets (m)2111589
Non Current Assets (m)66
Total Assets (m)211151415
Current Liabilities (m)111143
Total Liabilities (m)------
Total Equity (m)-11913711
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-1-5-3-6-9-8
Capital Expenditure (m)--
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
0.72
Last Price